v3.26.1
Summary of Significant Accounting Policies - Schedule of Sale Model (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Sale Model [Line Items]      
Total Revenue $ 61,791,957 $ 96,909,642 $ 97,098,915
Direct sales of disposable medical devices [Member]      
Schedule of Sale Model [Line Items]      
Revenue 5,821,022 6,766,636 8,077,373
Distributors sales of disposable medical devices [Member]      
Schedule of Sale Model [Line Items]      
Revenue 54,350,935 $ 90,143,006 $ 89,021,542
SaaS development service [Member]      
Schedule of Sale Model [Line Items]      
Revenue $ 1,620,000